GLOW GHK-CU (27mg) / BPC-157 (5mg) / TB500 (10mg)

What is GLOW – GHK-CU (27mg) / BPC-157 (5mg) / TB500 (10mg)?

GLOW is a multi-peptide research formulation categorized as a regenerative and cellular signaling peptide. This higher-concentration blend combines GHK-Cu, BPC-157, and TB500 into a single laboratory-grade preparation designed for structured experimental use.

Each peptide is commonly examined in research involving extracellular matrix biology, cellular communication, protein signaling pathways, and tissue-based laboratory models. The increased concentration format allows researchers to conduct extended or comparative studies within controlled in vitro environments.

This formulation is intended solely for laboratory research and is not approved for human or veterinary use.

Product Specifications

• CAS Numbers:
  • GHK-Cu: 49557-75-7
  • BPC-157: 137525-51-0
  • TB500: 885340-08-9
• Peptide Sequences:
  • GHK-Cu: Gly–His–Lys (copper-bound tripeptide)
  • BPC-157: Gly–Glu–Pro–Pro–Pro–Gly–Lys–Pro–Ala–Asp–Asp–Ala–Gly–Leu–Val
  • TB500: Synthetic fragment derived from Thymosin Beta-4
• Molecular Formulas:
  • GHK-Cu: C₁₄H₂4N₆O₄
  • BPC-157: C₆₂H₉₈N₁₆O₂₂
  • TB500: C₃₈H₆₈N₁₀O₁₄
• Purity: ≥99% (all components)
• Storage Conditions: Store at –20 °C; short‑term storage at 2–8 °C is acceptable. Protect from light.
• Intended Use: For laboratory research use only

Key Characteristics of GLOW – GHK-CU / BPC-157 / TB500

• Higher-concentration multi-peptide blend for enhanced research flexibility.
• Combines three structurally distinct peptides with defined sequences.
• High purity (≥99%) suitable for reproducible laboratory studies.
• Commonly examined in matrix biology and peptide signaling research.
• Designed for in vitro and preclinical experimental models.
• Supplied in a sealed research-grade vial format.
• Requires low-temperature storage to preserve molecular stability.
• Not intended for diagnostic, therapeutic, or clinical applications.

How GLOW – GHK-CU / BPC-157 / TB500 Supports Research

This advanced multi-peptide formulation is used in laboratory research to investigate peptide-driven signaling pathways, regulation of cellular structure, and interactions with the extracellular matrix.

By combining peptides studied in regenerative biology and protein modulation research, investigators can assess potential synergistic activity, pathway overlap, and comparative signaling behavior under controlled laboratory conditions.

Typical experimental endpoints include measurements of collagen and extracellular matrix protein expression, matrix metalloproteinase (MMP) and tissue inhibitor (TIMP) profiles, cell migration rates, and transcriptional changes in genes linked to structural proteins and cytoskeletal organization, depending on the model.

Each component of the blend (GHK-Cu, BPC-157, TB500) has been studied individually in regenerative and structural biology research. The combined formulation allows evaluation of single-peptide versus multi-peptide exposure under identical assay conditions, making it a powerful tool for exploring peptide interactions and comparing their effects.

Research Applications & Usage Information

GLOW – GHK-Cu / BPC-157 / TB500 (27mg / 5mg / 10mg) is commonly utilized in research involving:

• Cellular migration and proliferation models
• Extracellular matrix remodeling studies
• Collagen and structural protein signaling research
• Cytoskeletal dynamics and actin-related investigations
• In vitro tissue culture experiments
• Gene expression analysis related to structural and signaling pathways
• Comparative studies assessing single-peptide versus combination effects
• Long-term laboratory model evaluations requiring higher peptide availability

This product is supplied exclusively for laboratory research and must be used in accordance with institutional compliance and safety protocols.

Handling and Storage Recommendations

• Store at −20°C immediately upon receipt.
• Protect from direct light exposure.
• Keep the vial tightly sealed when not in use.
• Avoid repeated freeze-thaw cycles to maintain peptide integrity.
• Handle using appropriate laboratory protective equipment.
• Use aseptic technique during preparation or reconstitution (if applicable).

Proper storage and careful handling help maintain peptide integrity and ensure reliable experimental outcomes.

Research Use Only Notice

This product is intended for laboratory research use only and is not approved for human or veterinary use. It is not intended for diagnostic, therapeutic, or clinical applications. Any reference to biological activity or potential effects is based solely on preclinical or in-vitro findings and should not be interpreted as validated clinical outcomes. Researchers are responsible for ensuring proper handling, storage, and disposal in accordance with institutional, federal, and international guidelines.

References

1. Bajramagic S, Sever M, Rasic F, et al. Stable gastric pentadecapeptide BPC 157 and intestinal anastomoses therapy in rats—A review. Pharmaceuticals (Basel). 2024;17(8):1081. Published 2024 Aug 17. doi:10.3390/ph17081081. 
2. Sikiric P, Seiwerth S, Rucman R, et al. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract and wound healing. Curr Pharm Des. 2011;17(16):1612-1632. doi:10.2174/138161211796197179. 
3. Adnan SB, Maarof M, Fauzi MB, Fadilah NIM. Exploring the role of tripeptides in wound healing and skin regeneration: a comprehensive review. Int J Med Sci. 2025;22(16):4175-4200. Published 2025 Oct 1. doi:10.7150/ijms.11811.
4. Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987. doi:10.3390/ijms19071987. 
5. Sosne G, Qiu P, Goldstein AL, Wheater M. Biological activities of thymosin beta4 defined by active sites in short peptide sequences. FASEB J. 2010;24(7):2144-2151. doi:10.1096/fj.09-142307
6. Malinda KM, Goldstein AL, Kleinman HK. Thymosin beta 4 stimulates directional migration of human umbilical vein endothelial cells. FASEB J. 1997;11(6):474-481. doi:10.1096/fasebj.11.6.9194528